NO.2:ANXINSEC addressed the business interruption and data assets breaches for core business systems at GITEX GLOBAL 2022

BEIJING, Oct. 19, 2022 /PRNewswire/ — GITEX GLOBAL 2022 came to a successful conclusion. During the most influential event, ANXINSEC, as a memory security leader, presented its competitive product, MDPS (Memory Detection and Protection System), and several scenario-based security solutions. The MDPS (Memory Detection and Protection System) of ANXINSEC gained a lot of attention at GITEX.

Meanwhile, ANXINSEC was invited to participate in the Gitex Global 2022 Huawei Cloud TechWave Summit MEA and officially joined the Technologies Along Silk Road Alliance, which will jointly empower the Silk Road technology ecosystem and provide security solutions to more overseas customers.

With close ecological cooperation with Huawei, ANXINSEC has paid joint efforts to continuously provide security solutions for overseas customers, which is well acknowledged.

As cyber-crime costs enterprises hundreds of billions of dollars every year, cybersecurity has played a more critical role. As per World Economic Forum Global Cybersecurity outlook, 87% of top executives are planning to improve cyber resilience in their organization. Therefore, ANXINSEC’s focus at GITEX this year is to provide a Memory Detection and Protection System. Unlike other security products that only alarm without further action upon detection of malicious attacks, the MDPS from ANXINSEC can quietly defend against attacks before any damage is caused without affecting the businesses and data assets.

“In daily operations, when discovering a vulnerability exploit attack, the entire remediation process usually will take several days, weeks or even months, from the third party’s patch release, test environment verification, production environment verification to production environment deployment. This leaves a considerable risk of being attacked at all stages during this period. By having a memory-centric detection and protection system, the customers will have a new option to enhance their defense-in-depth system.  It’s expectable to improve their defensive power while minimizing the time and space for adversary/threat actors. For better serving and supporting the customers, Anxinsec also provides professional security services, to help our customers in fulfilling the gap and ensuring their business continuity and data security.” the technology expert explained to the visitors.

In the midst of the great wave of the digitalization process, ANXINSEC is committed to protecting the peace of the digital world.

Kpler releases its new crude supply & demand assessment tool to help professionals navigate uncertain crude markets

Kpler’s offering is the only one built on proprietary data and taking a systematic approach.

BRUSSELS, Oct. 19, 2022 /PRNewswire/ — Kpler, a fast-growing leader in technology-led data, analytics, and market insight, today launches a crude supply and demand (S&D) assessment tool to help market professionals and downstream consumers better navigate the turbulent and uncertain global crude markets.

Kpler Crude Supply and Demand (S&D) is based on three sets of proprietary data:

  • Kpler Crude Flows – past and real-time data on crude and condensates global trade flows
  • Kpler Crude Inventories – past and real-time data on crude storage facilities’ capacity utilisation
  • JBC Energy-inherited crude and refined products models, built on two decades’ worth of constant enhancements led by market experts

The three proprietary data sets have been combined to result in a powerful crude supply and demand assessment tool, providing users with current assessments of crude supply and demand at global, regional and country levels. These assessments are updated three times a month and forecasts extend to 18 months ahead; included components such as inventories changes or crude flows allow customers to see precisely how and why balances are changing.

The product represents a new approach to delivering crude S&D balances for market professionals by utilising Kpler’s best-in-class proprietary data and taking a systematic and integrated approach, compared to competitors that rely on disparate public information and are forced to model out certain elements that Kpler captures with its proprietary data.

Due to high market uncertainty and volatility – driven by the conflict in Ukraine and a looming economic recession – Kpler’s new product aims at helping market professionals better understand the current supply and demand dynamics. It will also help users to better anticipate balances and price developments, to build more efficient trading strategies.

François Cazor, Kpler’s CEO, commented: “Kpler’s new Crude Supply and Demand product demonstrates again our ability to integrate Kpler organic data sets with ones stemming from acquired companies, to build smart products that facilitate sustainable and efficient trade. Our new offering not only brings users’ great value in uncertain market times, it also stresses how our corporate and product roadmaps are aligned, as the acquisition of JBC Energy this year has proved instrumental in making this release possible.”

About Kpler:

Kpler is a fast-growing company on a mission to facilitate sustainable and efficient trade to meet the changing needs of our world. From numerous disparate and unstructured sources, Kpler creates technology-led data, analytics, and insight, that bring transparency to dynamic markets characterised by opaque and incomplete information, such as commodity and power markets. Kpler delivers its unique offering through technology solutions built in an agile and inventive way, enabling market professionals to make informed and timely trading decisions. Headquartered in Brussels, Kpler employs over 250 people across the world. Visit: www.kpler.com

Media contacts

Kpler
Arthur Chevreul
achevreul@kpler.com
+32 493 37 42 34

Paul O’Grady
PR Consultant
kpler@goodadvice.agency
+49 176 82374030

LeddarTech Brings Raw Data Fusion and Perception Software Technology to November Automotive Events in Motor City Detroit

LeddarTech Has Been Selected as One of Canada’s Top Growing Companies

LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce its recognition among Canada’s Top Growing Companies for 2022 by the Globe and Mail’s Report on Business, where LeddarTech ranked 280 out of 430 eligible companies.

QUEBEC CITY, Oct. 19, 2022 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and A.D. software technology, is pleased to announce its participation at two key automotive events in Detroit, Michigan where it will demonstrate LeddarVision™, a unique raw data sensor fusion and perception solution that enables the mass deployment of ADAS and autonomous driving solutions.

The LeddarTech technical and management team looks forward to demonstrating its technology at these two upcoming events:

American Automotive Summit – November 1-2 MGM Grand Detroit

The American Automotive Summit serves as an annual platform to exchange ideas surrounding the impact of market dynamics and new technologies for current and future automotive leaders. Network with over 150 of your peers, connect with exhibitors and learn from the top industry influencers and executives involved in manufacturing, operations, design, engineering, supply chain quality, and innovation.

  • Presentation by Frantz Saintellemy, President and COO of LeddarTech at 12:10 EST on November 2nd

    Topic:
    “Sensing and Perception Technology – Critical Challenges and Solutions for ADAS and AD”In this presentation, learn about the transition to software-defined vehicles and sensing and perception technology’s role in it.

Tech.AD USANovember 1315 The Henry Hotel Detroit

Tech.AD USA is the leading knowledge exchange platform in North America, bringing together 250+ stakeholders who play an active role in the vehicle automation scene.

LeddarTech Presents: LeddarVision raw data sensor fusion and perception technology

  • LeddarTech Showcase Booth: 1
    Our technical experts will demonstrate how raw data fusion technology simplifies complex sensor sets and eliminates the dependency on hardware to provide customers the flexibility to scale and deliver greater ADAS and AD performance quickly.

About LeddarTech

Founded in 2007, LeddarTech is an automotive ADAS and AD software company that offers comprehensive end-to-end raw data fusion and perception solutions enabling customers to solve critical challenges across the entire value chain.

LeddarTech’s automotive-grade software technology, LeddarVision™, is a flexible, robust, cost-effective, sensor-agnostic solution that delivers highly accurate 3D environmental models. This scalable software supports all SAE autonomy levels by applying AI and computer vision algorithms to fuse raw data from sensors employed in L2-L5 applications. LeddarTech’s use of raw data fusion detects very small obstacles on the road with better detection rates and fewer false alarms than legacy “object fusion” solutions. In addition, unclassified obstacles are also detected, providing an additional layer of safety to the vehicle.

LeddarTech is responsible for several innovations in cutting-edge automotive and mobility applications, with over 140 patents granted or applied for, enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@leddartech.com

Investor relations contact: InvestorRelations@leddartech.com
https://investors.leddartech.com/

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, LeddarEcho, VAYADrive, VayaVision, XLRator and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/982d222e-d193-4c43-a508-d3621411c300

Nyxoah to Release Third Quarter Financial Results on November 8, 2022

Nyxoah to Release Third Quarter Financial Results on November 8, 2022

Mont-Saint-Guibert, Belgium – October 18, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the third quarter of 2022 on Tuesday, November 8, 2022, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.

Investors interested in listening to the conference call may do so by registering for a unique personal PIN at the following link: https://register.vevent.com/register/BI0d7e0daed6e34e548b85e51146400c1a. A live and archived webcast of the event will be available on the Company’s investor relations website at https://investors.nyxoah.com/events.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contacts:
Nyxoah
Loic Moreau, Chief Financial Officer
corporate@nyxoah.com
+32 473 33 19 80

Jeremy Feffer, VP IR and Corporate Communications
jeremy.feffer@nyxoah.com
+1 917 749 1494

Attachment

‫الاختبار المنزلي للأجسام المضادة لكوفيد-19iStatis من شركة bioLytical Laboratories Inc يحصل على التأهيل المسبق من منظمة الصحة العالمية

أعلنت شركة bioLytical Laboratories Inc عن دخولها الفوري إلى أسواق إفريقيا وآسيا والشرق الأوسط وأمريكا الجنوبية بالاختبار الذاتي للأجسام المضادة لكوفيد-19على منصة الفحوص السريعة الجديدة iStatis

  • المنصة الجديدة iStatis أطلقتها bioLytical، صانعو®INSTI‎، لضمان حصول كل شخص في العالم على اختبارات تحوز ثقتهم
  • شركة bioLytical تحصل على الأهلية للاختبار الذاتي، الاختبار المنزلي للأجسام المضادة لكوفيد 19‏iStatis، لوكالات اللوازم الدولية والإقليمية والوطنية، للدخول الفوري إلى أسواق إفريقيا وآسيا والشرق الأوسط وأمريكا الجنوبية
  • الاختبار سهل الحمل ويمكن إجراؤه في العديد من الأماكن مع نتائج سهلة الفهم
  • أظهر اختبار الأداء في الدراسات التحليلية دقة عالية، مع حساسية وخصوصية رائدتين في الصناعة
  • نظام الجودة في bioLytical هو ضمن برنامج التدقيق الفردي للأجهزة الطبية (MDSAP): حاصل على شهادة الجودة أيزو ISO 13485

ريتشموند، كولومبيا البريطانية، 18 أكتوبر/تشرين الأول 2022 (خدمة الأخبار العالمية) – أعلنت شركة bioLytical Laboratories Inc. (“bioLytical”)، الشركة العالمية الرائدة في مجال التشخيص الطبي السريع في المختبرات، حصولها على التأهيل المسبق من منظمة الصحة العالمية لاختبارها الذاتي، الاختبار المنزلي للأجسام المضادة لكوفيد-19 iStatis، ما يسمح بدخولها الفوري إلى الأسواق الدولية.

واستكمالاً لما حققته شركة bioLytical بمنصة اختبار®INSTI‎ المبتكرة، فقد أطلقت برنامج iStatis مواصلةً لجهودها في توفير اختبارات جديرة بالثقة. ومع ما أنجزته شركة bioLytical من تقنية الفحوص السريعة الجديدة، تستطيع الآن خدمة أشخاص أكثر بإنجازاتها، لتحقيق عدالة التوافر للاختبار الذاتي السريع للأجسام المضادة لكوفيد-19 الذي يحقق راحة البال مع الدقة الرائدة في الصناعة.

وقد قال روب ماكي، الرئيس التنفيذي لشركة bioLytical: “نحن متحمسون للإعلان عن iStatis في المزيد من الأسواق العالمية بعد حصول اختبارنا الذاتي السريع للأجسام المضادة لكوفيد-19 على التأهيل المسبق لمنظمة الصحة العالمية. فقد رأينا فرصة لضخ اختبارات سريعة في أسواق أكثر في المناطق العالمية المختلفة التي لا تتوافر فيها الاختبارات عالية الجودة. وإننا فخورون بالعمل مع منظمة الصحة العالمية لمساعدة الأسواق المحرومة والإتاحة العادلة للاختبار على مستوى العالم”.

مع الطبيعة غير المتوقعة للجائحة، ستظل الاختبارات تؤدي دورًا رئيسيًا في مكافحة كوفيد-19 كحائط دفاعي آخر للحفاظ على أمان المجتمعات. ومع تباين مستويات العدوى في مناطق عالمية مختلفة، يساعد الاختبار الذاتي للأجسام المضادة لكوفيد-19 iStatis في توفير أرضية صلبة عن طريق تحديد العدوى. كما يساعد توفير الاختبار في المنزل للأفراد في تقليل العبء على المرافق الطبية المزدحمة. وبفضل دقته العالية وإمكانية نقله وسهولة استخدامه، تعمل bioLytical على توفير الاختبار السريع مع iStatis إلى كل المحتاجين في العالم.

ستصنع شركة bioLytical الاختبارات الذاتية لكوفيد-19 iStatis في: منشأتها التابعة لبرنامج التدقيق الفردي للأجهزة الطبية (MDSAP)، وهي حاصلة على اعتماد شهادة الأيزو ISO 13485، ومقرها في ريتشموند، كولومبيا البريطانية. بصفتها شركة عالمية رائدة في تشخيص الأمراض المعدية فائقة السرعة، تعمل bioLytical على ضمان توفر مجموعات اختبار iStatis في الأسواق الدولية مثل إفريقيا وآسيا والشرق الأوسط وأمريكا الجنوبية. وقد حصل الاختبار المنزلي للأجسام المضادة لكوفيد-19 iStatis أيضًا على ترخيص وزارة الصحة الكندية وعلامة CE للاختبار الذاتي في جميع أنحاء كندا وأوروبا.

هذا وتعتبر شركة bioLytical Laboratories Inc.‎ شركة قطاع خاص كندية تعمل في مجالات البحث والتطوير والتسويق التجاري للتشخيصات الطبية السريعة في المختبرات، باستخدام منصتها التكنولوجية INSTI®‎ وخط الفحوص السريعة iStatis. وفازت bioLytical بالعديد من الجوائز المحلية والصناعية، بما في ذلك مُصدِّر العام في 2019 في بريتش كولومبيا. لقد حزنا لقب الشركة التقنية الطبيعة النامية لهذا العام في مجال علوم الحياة في بريتش كولومبيا، كما وشكّلنا مادة إعلامية دسمة بصفتنا أسرع الشركات نموًا في بريتيش كولومبيا لست أعوام على التوالي، ومن ذلك دخولنا في قائمة الشركات الأسرع نموًا في عام 2020 لصحيفة جلوب أنجد ميل. وقد انتقلت bioLytical إلى مقر أحدث وأكبر بكثير، في ريتشموند، كولومبيا البريطانية، في عام 2020 لاستيعاب النمو الكبير الذي حققه فريقنا. من خلال تقديم نتائج دقيقة في دقيقة واحدة أو أقل، تشتمل مجموعة INSTI®‎ على اختبار الأجسام المضادة INSTI® HIV-1/HIV-2، واختبار INSTI® Multiplex HIV Syphilis Ab، واختبار INSTI® HIV الذاتي، واختبار الأجسام المضادة لكوفيد-19 INSTI®‎، واختبار الأجسام المضادة INSTI® HCV. تطرح bioLytical منتجاتها للبيع في أوروبا وأمريكا الشمالية وأمريكا الجنوبية وأفريقيا وآسيا. أطلقت bioLytical منصة iStatis في عام 2022، وهي منصتها الجديدة لاختبار الفحوص السريعة لتوفير إتاحة أكبر للاختبار في جميع أنحاء العالم.

ومن خلال تقديم نتائج دقيقة في الوقت الفعلي، تقدم INSTI®‎ وiStatis نتائج مهمة للمختصين الطبيين والمرضى ومؤسسات الصحة العامة في جميع أنحاء العالم، كما وتعتبر شريكًا مهمًا في معالجة بعض أكثر تحديات الرعاية الصحية خطورة في العالم. تفضل بزيارة www.istatis.com و www.insti.com و www.biolytical.com للاطلاع على مزيد من المعلومات.

المراجع
https://www.who.int/publications/i/item/WHO-2019-nCoV-SurveillanceGuidance-2022.1

تتوفر الصورة المرافقة لهذا الإعلان على: https://prdesk.globenewswire.com/api/ResourceLibraryFile/DownloadFile?source=pnr&Id=1f99cf04-8303-4204-8a66-fe352eb5f47e

جهة الاتصال الإعلامي

قسم الاتصالات في bioLytical

press@biolytical.com

‎+1-778-238-9340

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Olo Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OLO

NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Olo Inc. (NYSE: OLO) between August 11, 2021 and August 11, 2022, both dates inclusive (the “Class Period”), of the important November 28, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Olo securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Olo class action, go to https://rosenlegal.com/submit-form/?case_id=8131 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 28, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Subway was ending its contract with Olo; (2) Olo’s key business metric – active locations – could not continue to grow as defendants touted due to the loss of Subway’s business; and (3) as a result of the above, defendants’ statements about Olo’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Olo class action, go to https://rosenlegal.com/submit-form/?case_id=8131 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com